Rankings
▼
Calendar
IART Q1 2017 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena
IART
Integra LifeSciences Holdings Corporation
$747M
Q1 2017 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$259M
+9.2% YoY
Gross Profit
$172M
66.5% margin
Operating Income
$10M
3.9% margin
Net Income
$6M
2.5% margin
EPS (Diluted)
$0.08
QoQ Revenue Growth
+1.2%
Cash Flow
Operating Cash Flow
$29M
Free Cash Flow
$20M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$2.0B
Total Liabilities
$1.2B
Stockholders' Equity
$852M
Cash & Equivalents
$124M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$259M
$237M
+9.2%
Gross Profit
$172M
$152M
+13.2%
Operating Income
$10M
$22M
-55.0%
Net Income
$6M
$12M
-45.1%
Revenue Segments
Specialty Surgical Solutions
$156M
60%
Orthopedics and Tissue Technologies
$102M
40%
Geographic Segments
UNITED STATES
$201M
78%
Europe
$29M
11%
Rest Of World
$29M
11%
← FY 2017
All Quarters
Q2 2017 →